A counseling framework for moderate-penetrance colorectal cancer susceptibility genes

被引：27
作者：
Katona, Bryson W. [1 ]
Yurgelun, Matthew B. [2 ,3 ]
Garber, Judy E. [2 ,3 ]
Offit, Kenneth [4 ,5 ]
Domchek, Susan M. [1 ]
Robson, Mark E. [4 ,5 ]
Stadler, Zsofia K. [4 ,5 ]
机构：
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, 1275 York Ave, New York, NY 10021 USA
[5] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
来源：
GENETICS IN MEDICINE | 2018年 / 20卷 / 11期
基金：
美国国家卫生研究院;
关键词：
MUTATIONS; METAANALYSIS; VARIANT; RISK;
D O I：
10.1038/gim.2018.12
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：1324 / 1327
页数：4
相关论文
共 15 条
  • [1] Colorectal cancer and the CHEK2 1100delC mutation
    de Jong, MM
    Nolte, IM
    Meerman, GJT
    van der Graaf, WTA
    Mulder, MJ
    van der Steege, G
    Bruinenberg, M
    Schaapveld, M
    Niessen, RC
    Berends, MJW
    Sijmons, RH
    Hofstra, RMW
    de Vries, EGE
    Kleibeuker, JH
    [J]. GENES CHROMOSOMES & CANCER, 2005, 43 (04) : 377 - 382
  • [2] Howlader N, SEER CANC STAT REV 1
  • [3] Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x
  • [4] Colorectal cancer risk associated with the CHEK2 1100delC variant
    Katona, Bryson W.
    Yang, Yu-Xiao
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 83 : 103 - 105
  • [5] Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer
    Kurian, Allison W.
    Li, Yun
    Hamilton, Ann S.
    Ward, Kevin C.
    Hawley, Sarah T.
    Morrow, Monica
    McLeod, M. Chandler
    Jagsi, Reshma
    Katz, Steven J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (20) : 2232 - +
  • [6] The CHEK2 I157T Variant and Colorectal Cancer Susceptibility: A Systematic Review and Meta-analysis
    Liu, Chuan
    Wang, Qing-Shui
    Wang, Ya-Jie
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (05) : 2051 - 2055
  • [7] Locker Gershon Y, 2004, Fam Cancer, V3, P215
  • [8] Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence
    Ma, Xiangyu
    Zhang, Ben
    Zheng, Wei
    [J]. GUT, 2014, 63 (02) : 326 - 336
  • [9] Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
    Meijers-Heijboer, H
    van den Ouweland, A
    Klijn, J
    Wasielewski, M
    de Snoo, A
    Oldenburg, R
    Hollestelle, A
    Houben, M
    Crepin, E
    van Veghel-Plandsoen, M
    Elstrodt, F
    van Duijn, C
    Bartels, C
    Meijers, C
    Schutte, M
    McGuffog, L
    Thompson, D
    Easton, DF
    Sodha, N
    Seal, S
    Barfoot, R
    Mangion, J
    Chang-Claude, J
    Eccles, D
    Eeles, R
    Evans, DG
    Houlston, R
    Murday, V
    Narod, S
    Peretz, T
    Peto, J
    Phelan, C
    Zhang, HX
    Szabo, C
    Devilee, P
    Goldgar, D
    Futreal, PA
    Nathanson, KL
    Weber, BL
    Rahman, N
    Stratton, MR
    [J]. NATURE GENETICS, 2002, 31 (01) : 55 - 59
  • [10] National Comprehensive Cancer Network Guidelines, Genetic/familial high-risk asssessment: Breast and ovarian
12